Vatsalya Dental to Set up India’s First Innovation Program in Dentistry

IMT News Desk
IMT News Desk
· 3 min read

In a bid to create a spirit of entrepreneurship and innovation in the healthcare space, India’s fastest growing chain of dental centers, Vatsalya Dental has collaborated with Origiin IP Solutions to set up a pan-India innovation programme in Dentistry. To be run from Vatsalyas world class and expansive 4,000sq. ft. Innovation and Incubation Centre, the programme aims to reach out to 1000 plus students and young dentists in India by 2018 end, and foster a culture of innovation and entrepreneurship, particularly in the space of dentistry.   

Origiin IP Solutions, considered to be among India’s top IP firms, along with Vatsalya Dental will help young students and dentists ideate, build and market their product giving them a competitive edge in the ecosystem. Together, they will expand the programme nationally and ensure that it meets the evolving healthcare demands with greater research and innovation.

The programme will also include a design and manufacturing partner who will be part of the initiative right from the ideation stage. This is a first of its kind programme, which will bring industry veterans and young dentists together, to build a world class dental infrastructure in India, and also further the cause of the Make in India’ initiative launched by Government of India.

Speaking on this initiative, Dr Srivats Bharadwaj, Chairman and Founder, Vatsalya Dental said, “This will be India’s first such programme fostering innovation in healthcare. We will be working with Dental colleges and young dentists across India and provide them with platforms that will help them not just ideate, but also execute and patent those ideas; thereby make a difference in the society. The partnership consists of a core team of innovators who will mentor young students and dentists through the year.

“In addition to the fact that Dentistry or Oral care as a healthcare subject is still a neglected in India, the medical devices used in dentistry are not always compatible to our needs as very often these products are researched and developed in US or UK and dont take into account the socio-cultural and medical/healthcare requirement of patients in India. These products, therefore don’t adhere to best practices from the Indian context and also comes with an exorbitant cost that ultimately is passed on to the patient. If we really aspire to make healthcare in India meet global standards, I sincerely believe that we need to work together to build, sustain and grow a scientific and policy ecosystem that promotes and rewards medical innovation. Innovation in the country will also drastically bring down the costs of equipment and treatment in India,” added Dr Bharadwaj while talking about the need to create an innovation friendly environment in India.  

“We are very excited about launching this programme with Vatsalya Dental, at a time when India is witnessing a surge in entrepreneurial spirit and innovation. In areas such as healthcare, researching and developing innovative products can provide real solutions for better healthcare and transform the lives of people. It can also fuel the growth of domestic innovation and bolster India’s economic prosperity,” said Raghu Ram from Origiin IP Solutions.  

In fact, some of the young innovators have already started working at the incubation center along with their mentors. “While we can’t disclose the innovation that they’re working on, we are enthused at the ability of these young students to think beyond classroom teachings and carry such powerful and creative concepts that can impact the industry,” said Bindu Sharma one of the mentors.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk